CT
VRTX icon

Coastline Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Coastline Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$213K Sell
407
-130
-24% -$66.6K 0.02% 184
2026
Q2 		$267K Hold
537
– – 0.02% 189
2026
Q1 		$240K Sell
537
-60
-10% -$28K 0.02% 195
2025
Q4 		$271K Hold
597
– – 0.03% 192
2025
Q3 		$234K Sell
597
-3,145
-84% -$1.31M 0.03% 187
2025
Q2 		$1.67M Hold
3,742
– – 0.19% 92
2025
Q1 		$1.81M Buy
3,742
+225
+6% +$105K 0.23% 89
2024
Q4 		$1.42M Sell
3,517
-3,062
-47% -$1.42M 0.17% 105
2024
Q3 		$3.06M Buy
6,579
+760
+13% +$365K 0.36% 61
2024
Q2 		$2.73M Buy
5,819
+20
+0.3% +$8.68K 0.32% 71
2024
Q1 		$2.42M Buy
5,799
+4,784
+471% +$2.02M 0.29% 79
2023
Q4 		$413K Buy
+1,015
New +$375K 0.05% 203
2020
Q4 		– Sell
-1,150
Closed -$313K – 324
2020
Q3 		$313K Sell
1,150
-400
-26% -$110K 0.05% 264
2020
Q2 		$450K Hold
1,550
– – 0.07% 243
2020
Q1 		$369K Hold
1,550
– – 0.07% 246
2019
Q4 		$339K Sell
1,550
-9
-0.6% -$1.82K 0.05% 282
2019
Q3 		$264K Buy
+1,559
New +$276K 0.04% 292

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Coastline Trust's VRTX Position: Q3 2026 in Review

Coastline Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 24% in Q3 2026, selling an estimated $66.6K and leaving 407 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #184.

Coastline Trust first reported a position in VRTX in Q3 2019 and has held it in 17 quarters since. The position peaked at $3.06M in Q3 2024. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Coastline Trust held 407 shares of Vertex Pharmaceuticals worth $213K as of Q3 2026.
  • Coastline Trust sold 130 Vertex Pharmaceuticals shares in Q3 2026, an estimated $66.6K.
  • Vertex Pharmaceuticals made up 0.02% of Coastline Trust's portfolio in Q3 2026, its #184 holding.
  • Coastline Trust first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 17 quarters since.
  • Coastline Trust's Vertex Pharmaceuticals position peaked at $3.06M in Q3 2024.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Coastline Trust's 13F filing for Q3 2026, filed 1 Oct 2026.